The FcRn inhibitor rozanolixizumab reduces human serum IgG...

Science Translational Medicine 2017 / 11 Vol. 9; Iss. 414

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study

Kiessling, Peter, Lledo-Garcia, Rocio, Watanabe, Shikiko, Langdon, Grant, Tran, Diep, Bari, Muhammad, Christodoulou, Louis, Jones, Emma, Price, Graham, Smith, Bryan, Brennan, Frank, White, Ian, Jolles
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.aan1208
Date:
November, 2017
File:
PDF, 618 KB
english, 2017
Conversion to is in progress
Conversion to is failed